TGOD Rolls Out Highly Dutch Organic

TGOD Rolls Out Highly Dutch Organic

Highly Dutch expands market potential to approximately 70% of the Canadian market compared to 25% for the premium segmentDual branding strategy addresses both premium and mainstream consumerFirst certified organic 28-gram product in Canada targets daily users and helps convert illicit market to safe legal sourcesLeverages TGOD’s unmatched capabilities to produce certified organic cannabis at scale…

Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors

Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors

SAN DIEGO, June 4, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has appointed biotechnology and pharmaceutical industry veteran Terrence O. Tormey to the company’s Board of…

CBD Laws & Laws in the United States and Other Nations

CBD Laws & Laws in the United States and Other Nations

Brooklyn Bridge (photo: Toms Rits) The CBD industry is thriving. For starters, the growing concerns over prescription pain medications have led more people to seek alternatives. The industry has also grown because of increased public awareness about how effective CBD is and how many health benefits it may offer. However, laws have not always kept…

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

SAN DIEGO, May 28, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has expanded its research division through the establishment of…